ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
34 hedge funds and large institutions have $18.1M invested in Acorda Therapeutics in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
50% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 12
Holders
34
Holding in Top 10
–
Calls
$749K
Puts
$893K
Top Buyers
| 1 | +$937K | |
| 2 | +$325K | |
| 3 | +$235K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$213K |
| 5 |
State Street
Boston,
Massachusetts
|
+$151K |
Top Sellers
| 1 | -$543K | |
| 2 | -$478K | |
| 3 | -$311K | |
| 4 |
QI
QS Investors
New York
|
-$247K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$229K |